[Federal Register Volume 85, Number 77 (Tuesday, April 21, 2020)]
[Notices]
[Pages 22178-22179]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08354]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-606]


Importer of Controlled Substances Application: Sigma Aldrich Co., 
LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturer of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before May 21, 2020. 
Such persons may also file a written request for a hearing on the 
application on or before May 21, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on January 27, 2020, Sigma Aldrich Co., LLC, 3500 DeKalb 
Street, Saint Louis, Missouri 63118 applied to be registered as an 
importer of the following basic class(es) of controlled substances:

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Cathinone..........................            1235  I
Methcathinone......................            1237  I
Mephedrone (4-Methyl-N-                        1248  I
 methylcathinone).
Gamma Hydroxybutyric Acid..........            2010  I
Tetrahydrocannabinols..............            7370  I
4-Bromo-2,5-dimethoxyamphetamine...            7391  I
4-Bromo-2,5-dimethoxyphenethylamine            7392  I
2,5-Dimethoxyamphetamine...........            7396  I
3,4-Methylenedioxyamphetamine......            7400  I
3,4-Methylenedioxy-N-                          7404  I
 ethylamphetamine.
3,4-Methylenedioxymethamphetamine..            7405  I
4-Methoxyamphetamine...............            7411  I
Dimethyltryptamine.................            7435  I
N-Benzylpiperazine.................            7493  I
Heroin.............................            9200  I
Normorphine........................            9313  I
Amobarbital........................            2125  II
Secobarbital.......................            2315  II
Nabilone...........................            7379  II
Phencyclidine......................            7471  II
Ecgonine...........................            9180  II
Ethylmorphine......................            9190  II

[[Page 22179]]

 
Levorphanol........................            9220  II
Meperidine.........................            9230  II
Thebaine...........................            9333  II
Opium, powdered....................            9639  II
Levo-alphacetylmethadol............            9648  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
sale to research facilities for drug testing and analysis. In reference 
to drug code 7370 (Tetrahydrocannabinols) the company plans to import 
synthetic tetrahydrocannabinols. No other activities for these drug 
codes are authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-08354 Filed 4-20-20; 8:45 am]
BILLING CODE 4410-09-P